Ondansetron Injection, Solution
Product Images NDC 76045-216

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 76045-216). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ond06 0005 01

FDA Label Image

Ond06 0005 02

FDA Label Image

Ond06 0005 03

FDA Label Image

Ond06 0005 04

FDA Label Image

Ond06 0005 05

FDA Label Image

Ond06 0005 06

This is a product information sheet for Ondansetron Injection, USP, which is a drug administered intravenously or intramuscularly for nausea and vomiting. The provided information includes the drug name, NDC code (76045-216-20), dosage strength (4 g/2 mi or 2mg/mt), and package size (24 x 2mL prefilled single-use syringes). There are also instructions to discard any unused portion of the medication, and a warning not to place the syringe in a sterile field. Additionally, there are some illegible sections and some non-English text which cannot be translated.*

FDA Label Image

Ond06 0005 07

This is a description for Ondansetron, an injection that comes in a 2 mL prefilled single-use syringe with 4 mg/2mL (2mg/mL) concentration for IV or IM use only. Dilution is required prior to administration for chemotherapy-induced nausea and vomiting, and a full prefilled syringe is necessary for postoperative. It is important to store this medication at 20° to 25°C (68° to 77°) and protect it from light. It may also be refrigerated at 2°-8°C (36* 46°F). The usual dosage is described in the package insert, and unused portions should be discarded. Pediatric patients under 40 kg should not use the medication for nausea and vomiting. The expiration date is not available, and the lot number is 0000000.*

FDA Label Image

Ond06 0005 08

This is a description of a medicine solution called Ondansetron Injection which is available for IV or IM use in single dose of 2 mL. It is manufactured by a company called Fresenius Kabi and contains 4 mg of Ondansetron per 2 mL. Dilution of the solution is required before use. This medicine is used for chemotherapy induced nausea and vomiting. The provided text also includes other details such as some codes and instructions but it's not clear what they refer to specifically.*

FDA Label Image

Ond06 0005 09

FDA Label Image

Ond06 0005 10

Ondansetron injection is a prescription drug that helps alleviate chemotherapy-induced nausea and vomiting. Dilution is required before administering. The solution comes in a single-use prefilled syringe, which is not recommended for pediatric patients under 40 kg. It's not recommended to store the injection at temperatures below 2° C or above 25°C. Do not expose it to light, and do not dilute it for IV push. Unused portions should be discarded, and the syringe should not be placed on a sterile field. The usual dosage information can be found in the package insert.*

FDA Label Image

Ond06 0005 11

This is a medication description for Ondansetron Injection, USP which is used for Intravenous or Intramuscular treatment. The available dosage is 2mL for single-use. The medication contains 4mg/2mL of Ondansetron and requires dilution for chemotherapy-induced nausea and vomiting. The remaining text is unreadable.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.